Recent Patents on Anti-Cancer Drug Discovery
Published by Bentham Science Publishers
ISSN : 1574-8928 eISSN : 2212-3970
Abbreviation : Recent Pat. Anti-cancer Drug Discov.
Aims & Scope
Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers.
The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery.
A selection of important and recent patents on anti-cancer drug discovery is also included in the journal.
The journal is essential reading for all researchers involved in anti-cancer drug design and discovery.
The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 4.1 |
| 2024 | 2.50 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.667 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q2 |
h-index
| Year | Value |
|---|---|
| 2024 | 54 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 8584 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 410 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Advances in Chalcones with Anticancer Activities
Citation: 222
Authors: Chandrabose, Narayana S.H., Sakthivel, Uma, Elangovan, Devarajan, Piyush
-
Recent Developments in the Field of Anticancer Platinum Complexes
Citation: 190
Authors: Mathea Sophia
-
HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Citation: 188
Authors: Katerina, Evangelia
-
Nanoparticle Albumin - Bound (NAB) Technology is a Promising Method for Anti-Cancer Drug Delivery
Citation: 136
Authors: Qiang, Jin, Wenping, Xiaofan, Zhongtian, Zhonggui
-
Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
Citation: 132
Authors: Sandra, Pascale
-
PARP Inhibitors in Ovarian Cancer
Citation: 129
Authors: Gloria, Eleonora, Gaia, Sofia, Massimo, Anna, Giorgio
-
Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway
Citation: 122
Authors: Kwong-Kwok